Official Title
Effect of Early Corticosteroid Therapy on Mortality in Patient With Acute Respiratory Distress Syndrome Secondary to Covid-19
Brief Summary

Study conducted on hospitalized patient in critical ill units in Nancy and Metz to evaluate if early corticosteroid treatment in first seven days after admission improve patients outcome in Acute Respiratory Distress Syndrome secondary to Covid-19 compared to later corticosteroid therapy or no treatment. Also comparison of acquired infection with or without corticosteroid treatment during hospitalisation.

Status
Unknown status
Conditions
Acute Respiratory Distress Syndrome Secondary to Covid-19
Interventions

Drug: Corticosteroids and Derivatives

Any systemic corticosteroid treatment administrated during ICU stay

Eligibility Criteria

Inclusion Criteria:

- ICU hospitalized with acute respiratory distress syndrome secondary to Sars-Cov-2
infection diagnosed by PCR test

- Hospitalized from 01/03/2020 to 30/04/2020

Exclusion Criteria:

- Mechanical ventilation more than 48 hours at admission

- Transfert to another ICU during stay for bed management

- Corticosteroid treatment at admission

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Hopital Central, Service de Reanimation Medicale
Nancy, France

Investigators

Sebastien GIBOT, Principal Investigator
Central Hospital, Nancy, France

Sponsors / Collaborators
Central Hospital, Nancy, France
NCT Number
NCT04586114
MeSH Terms
COVID-19
Neoplasm Metastasis
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Newborn
Acute Lung Injury
Syndrome